+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension



Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension



Anadolu Kardiyoloji Dergisi 10(Suppl. 1): 63-68



Idiopathic pulmonary arterial hypertension (PAH) is included in Group 1 of PAH classification, while pulmonary veno-occlusive disease (PVOD), pulmonary capillary hemangiomatosis (PCH), portopulmonary hypertension (PoPH) and HIV-associated PAH constitute the subgroups of Group I PAH disorders. PVOD has similar clinical presentation, hemodynamic characteristics and genetic background with PAH although main pathology is in venules and definite diagnosis is done by biopsy although not recommended due to high risk of bleeding. PCH, a rare idiopathic lung disorder, causes PAH in young adults and mostly is diagnosed after death by autopsy. PoPH is defined as PAH due to primary chronic liver disease associated with intrapulmonary vascular dilatations and hypoxia. HIV associated PAH is a rare complication of HIV-infection, and it is seen especially in HIV-infected patients with intravenous drug abuse.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054803039

Download citation: RISBibTeXText

PMID: 20819769

DOI: 10.5152/akd.2010.121


Related references

Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Research and Therapy 13(2): R61, 2011

Platelet-derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive dise. 2011

Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary vasodilator therapy. Journal of Cardiology Cases 5(3): E175-E178, 2012

Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival. American Heart Journal 162(3): 562-568, 2011

Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. Arthritis and Rheumatism 58(4): 1156-1164, 2008

Pulmonary veno-occlusive disease - a rare form of pulmonary arterial hypertension. Deutsche Medizinische Wochenschrift 133(Suppl. 6): S212-S214, 2008

Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension. European Respiratory Review 18(113): 177-180, 2009

A Novel Mutation In A Patient With Pulmonary Veno-Occlusive Disease Masquerading As Pulmonary Arterial Hypertension. Chest 154(4): 1021A-1022A, 2018

Cytotoxic cells and granulysin in pulmonary arterial hypertension and pulmonary veno-occlusive disease. American Journal of Respiratory and Critical Care Medicine 187(2): 189-196, 2013

Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences. Seminars in Respiratory and Critical Care Medicine 30(4): 411-420, 2009

Pulmonary veno-occlusive disease as a cause of pulmonary arterial hypertension. Proceedings 28(3): 350-352, 2015

Prognostic significance of computed tomography criteria for pulmonary veno-occlusive disease in systemic sclerosis-pulmonary arterial hypertension. Rheumatology 56(12): 2197-2203, 2017

First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease. Pulmonary Circulation 3(4): 952-958, 2013

Pulmonary hypertension/pulmonary arterial hypertension in congenital heart disease and therapy of pulmonary arterial hypertension in children. Deutsche Medizinische Wochenschrift 139(Suppl. 4): S166-S170, 2015

Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis. Pulmonary Circulation 4(2): 342-345, 2014